DE3382621T2 - Zwischenprodukte fuer die herstellung von cephemverbindungen, verfahren zu ihrer herstellung und ihre anwendung. - Google Patents

Zwischenprodukte fuer die herstellung von cephemverbindungen, verfahren zu ihrer herstellung und ihre anwendung.

Info

Publication number
DE3382621T2
DE3382621T2 DE8888102767T DE3382621T DE3382621T2 DE 3382621 T2 DE3382621 T2 DE 3382621T2 DE 8888102767 T DE8888102767 T DE 8888102767T DE 3382621 T DE3382621 T DE 3382621T DE 3382621 T2 DE3382621 T2 DE 3382621T2
Authority
DE
Germany
Prior art keywords
compound
salt
acid
reaction
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888102767T
Other languages
German (de)
English (en)
Other versions
DE3382621D1 (de
Inventor
Jiro Goto
Kazuo Sakane
Tsutomu Teraji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838305799A external-priority patent/GB8305799D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3382621D1 publication Critical patent/DE3382621D1/de
Publication of DE3382621T2 publication Critical patent/DE3382621T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/081,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DE8888102767T 1982-07-19 1983-07-15 Zwischenprodukte fuer die herstellung von cephemverbindungen, verfahren zu ihrer herstellung und ihre anwendung. Expired - Fee Related DE3382621T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8220833 1982-07-19
GB838305799A GB8305799D0 (en) 1983-03-02 1983-03-02 Cephem compounds

Publications (2)

Publication Number Publication Date
DE3382621D1 DE3382621D1 (de) 1992-10-15
DE3382621T2 true DE3382621T2 (de) 1993-02-18

Family

ID=26283377

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8888102767T Expired - Fee Related DE3382621T2 (de) 1982-07-19 1983-07-15 Zwischenprodukte fuer die herstellung von cephemverbindungen, verfahren zu ihrer herstellung und ihre anwendung.
DE8383106933T Expired DE3380627D1 (en) 1982-07-19 1983-07-15 Cephem compounds, process and intermediates for their preparation and pharmaceutical compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8383106933T Expired DE3380627D1 (en) 1982-07-19 1983-07-15 Cephem compounds, process and intermediates for their preparation and pharmaceutical compositions containing them

Country Status (4)

Country Link
US (3) US4563449A (enExample)
EP (2) EP0099553B1 (enExample)
JP (2) JPH0751591B2 (enExample)
DE (2) DE3382621T2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74822A (en) * 1984-04-17 1989-06-30 Daiichi Seiyaku Co Cephalosporin derivatives and salts thereof and their preparation
CA1293719C (en) * 1986-09-22 1991-12-31 Takao Takaya Cephem compounds and processes for preparation thereof
DE3722539A1 (de) * 1987-07-08 1989-01-19 Reichenecker Hans Storopack Geschaeumter formkoerper
IE61679B1 (en) * 1987-08-10 1994-11-16 Fujisawa Pharmaceutical Co Water-soluble antibiotic composition and water-soluble salts of new cephem compounds
US5958905A (en) 1996-03-26 1999-09-28 Texas Biotechnology Corporation Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
KR100361828B1 (ko) * 1997-04-16 2005-08-12 주식회사 엘지생명과학 반응성 유기산 유도체로 부터 세포탁심을 제조하는방법
KR100361829B1 (ko) * 1997-04-16 2005-08-17 주식회사 엘지생명과학 반응성 유기산 유도체로 부터 세프트리악손을 제조하는 방법
TW473479B (en) * 1997-12-19 2002-01-21 Takeda Chemical Industries Ltd Phosphonocephem derivatives, their production and use
EP3616695B1 (en) 2011-09-09 2024-10-23 Merck Sharp & Dohme LLC Ceftolozane/tazobactam for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274995A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Parenteral ceftolozane antibiotic compositions
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
AU2014233637A1 (en) 2013-09-09 2015-03-26 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE541421A (enExample) * 1954-10-26 1900-01-01
FR1210435A (fr) * 1958-09-26 1960-03-08 Cfmc Procédé de synthèse de la phosphocréatine
NL129633C (enExample) * 1965-03-05
FR1518199A (fr) * 1966-04-07 1968-03-22 Glaxo Lab Ltd Procédé de préparation d'antibiotiques du type de la céphalosporine
JPS5035079B1 (enExample) * 1970-10-17 1975-11-13
GB1391437A (en) * 1971-04-07 1975-04-23 Glaxo Lab Ltd Preparation of antibiotic compounds
US4268509A (en) * 1978-07-10 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds and processes for preparation thereof
AU536842B2 (en) * 1978-12-29 1984-05-24 Fujisawa Pharmaceutical Co., Ltd. Cephalosporin antibiotics
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds

Also Published As

Publication number Publication date
US4654422A (en) 1987-03-31
US4772682A (en) 1988-09-20
DE3380627D1 (en) 1989-11-02
EP0300121B1 (en) 1992-09-09
EP0099553B1 (en) 1989-09-27
US4563449A (en) 1986-01-07
JPH037296A (ja) 1991-01-14
EP0099553A3 (en) 1985-06-19
JPH0448796B2 (enExample) 1992-08-07
JPH0751591B2 (ja) 1995-06-05
DE3382621D1 (de) 1992-10-15
JPH037292A (ja) 1991-01-14
EP0300121A2 (en) 1989-01-25
EP0300121A3 (en) 1990-09-26
EP0099553A2 (en) 1984-02-01

Similar Documents

Publication Publication Date Title
DE2745246C2 (enExample)
DE3382621T2 (de) Zwischenprodukte fuer die herstellung von cephemverbindungen, verfahren zu ihrer herstellung und ihre anwendung.
DE3788261T2 (de) Cephemderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate.
DE3885688T2 (de) Cephemverbindungen und Verfahren zu ihrer Herstellung.
DE2707565C2 (enExample)
DE69531203T2 (de) Cephalosporinsynthese
DE3689684T2 (de) Cephemverbindungen und Verfahren zu ihrer Herstellung.
CH630923A5 (de) Verfahren zur herstellung von neuen cephalosporinderivaten.
DE2529941A1 (de) Azetidinonderivate und verfahren zu ihrer herstellung
EP0005830B1 (de) Cephalosporinderivate, deren Herstellung und die entsprechenden pharmazeutischen Präparate
DE68926981T2 (de) Cephemverbindungen und Verfahren zu ihrer Herstellung
CH641469A5 (de) In 3- und 7-stellung disubstituierte 3-cephem-4-carbonsaeurederivate.
DE2936434A1 (de) Cephemverbindungen, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische mittel sowie ihre therapeutische verwendung fuer die behandlung von infektionserkrankungen bei menschen und tieren
EP0112550A2 (de) Kristallisierte Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung
DE2625015A1 (de) 3-substituierte-7-substituiertealkanamido-3-cephem-4-carbonsaeure-verbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
DE3686979T2 (de) Cephemverbindungen und verfahren zu ihrer herstellung.
DE3005888C2 (enExample)
DE3789466T2 (de) 3,7-Disubstituierte-3-Cephemverbindungen und Verfahren zu ihrer Herstellung.
DE3688087T2 (de) Cephemverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
EP0280157B1 (de) Kristallisierte Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung
JPH01193273A (ja) 新規セフェム化合物
DE69430618T2 (de) Cephemverbindungen
CH645116A5 (de) Cephem-verbindungen, verfahren zu ihrer herstellung und sie enthaltende antibakterielle pharmazeutische mittel.
DE69028920T2 (de) Verfahren zur Herstellung von (1R,5S,6S)-2-[(6,7-Dihydro-5H-pyrazolo[1,2-a][1,2,4]triazolium-6-yl)thio]-6-[(R)-1-hydroxyethyl]-1-methyl-carbapenem-3-Carbonsäureester und deren Ausgangsverbindungen
CH634074A5 (de) Verfahren zur herstellung von neuen cephemcarbonsaeurederivaten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee